Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 3
1995 1
1996 1
1997 2
1998 1
1999 3
2000 4
2001 5
2002 3
2003 2
2004 13
2005 11
2006 10
2007 5
2008 5
2009 6
2010 13
2011 12
2012 10
2013 14
2014 13
2015 15
2016 18
2017 24
2018 27
2019 31
2020 27
2021 45
2022 40
2023 35
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

386 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, Green DF, Juncos LA, Beara-Lasic L, Blumenthal SS, Sussman AN, Erickson SB, Hladunewich M, Canetta PA, Hebert LA, Leung N, Radhakrishnan J, Reich HN, Parikh SV, Gipson DS, Lee DK, da Costa BR, Jüni P, Cattran DC; MENTOR Investigators. Fervenza FC, et al. Among authors: aslam n. N Engl J Med. 2019 Jul 4;381(1):36-46. doi: 10.1056/NEJMoa1814427. N Engl J Med. 2019. PMID: 31269364 Clinical Trial.
Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy.
Barbour SJ, Fervenza FC, Induruwage D, Brenchley PE, Rovin B, Hladunewich MA, Reich HN, Lafayette R, Aslam N, Appel GB, Zand L, Kiryluk K, Liu L, Cattran DC; MENTOR Trial Investigators. Barbour SJ, et al. Among authors: aslam n. Clin J Am Soc Nephrol. 2023 Oct 1;18(10):1283-1293. doi: 10.2215/CJN.0000000000000237. Epub 2023 Jul 20. Clin J Am Soc Nephrol. 2023. PMID: 37471101
Quantum sensors for biomedical applications.
Aslam N, Zhou H, Urbach EK, Turner MJ, Walsworth RL, Lukin MD, Park H. Aslam N, et al. Nat Rev Phys. 2023;5(3):157-169. doi: 10.1038/s42254-023-00558-3. Epub 2023 Feb 3. Nat Rev Phys. 2023. PMID: 36776813 Free PMC article. Review.
Metabolic and Bariatric Endoscopy: A Mini-Review.
Norton BC, Telese A, Papaefthymiou A, Aslam N, Makaronidis J, Murray C, Haidry R. Norton BC, et al. Among authors: aslam n. Life (Basel). 2023 Sep 13;13(9):1905. doi: 10.3390/life13091905. Life (Basel). 2023. PMID: 37763308 Free PMC article. Review.
Interagency working.
Nisar K, Aslam N. Nisar K, et al. Among authors: aslam n. Br Dent J. 2009 Jun 13;206(11):562; author reply 562-3. doi: 10.1038/sj.bdj.2009.482. Br Dent J. 2009. PMID: 19521359 No abstract available.
CRISPR/Cas9-Mediated Immunity in Plants Against Pathogens.
Sameeullah M, Khan FA, Özer G, Aslam N, Gurel E, Waheed MT, Karadeniz T. Sameeullah M, et al. Among authors: aslam n. Curr Issues Mol Biol. 2018;26:55-64. doi: 10.21775/cimb.026.055. Epub 2017 Sep 7. Curr Issues Mol Biol. 2018. PMID: 28879856 Free article. Review.
Food-drug interactions.
Bushra R, Aslam N, Khan AY. Bushra R, et al. Among authors: aslam n. Oman Med J. 2011 Mar;26(2):77-83. doi: 10.5001/omj.2011.21. Oman Med J. 2011. PMID: 22043389 Free PMC article.
The endoscopic management of oesophageal strictures.
Norton BC, Papaefthymiou A, Aslam N, Telese A, Murray C, Murino A, Johnson G, Haidry R. Norton BC, et al. Among authors: aslam n. Best Pract Res Clin Gastroenterol. 2024 Mar;69:101899. doi: 10.1016/j.bpg.2024.101899. Epub 2024 Feb 27. Best Pract Res Clin Gastroenterol. 2024. PMID: 38749578 Review.
386 results